191 related articles for article (PubMed ID: 36645398)
1. What's new in the WHO 2022 classification of kidney tumours?
Alaghehbandan R; Siadat F; Trpkov K
Pathologica; 2022 Feb; 115(1):8-22. PubMed ID: 36645398
[TBL] [Abstract][Full Text] [Related]
2. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H; Amin MB; Berney DM; Compérat EM; Gill AJ; Hartmann A; Menon S; Raspollini MR; Rubin MA; Srigley JR; Hoon Tan P; Tickoo SK; Tsuzuki T; Turajlic S; Cree I; Netto GJ
Eur Urol; 2022 Nov; 82(5):458-468. PubMed ID: 35853783
[TBL] [Abstract][Full Text] [Related]
3. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H
Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618
[TBL] [Abstract][Full Text] [Related]
4. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract][Full Text] [Related]
5. The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.
Kanakaraj J; Chang J; Hampton LJ; Smith SC
Urol Oncol; 2024 Jul; 42(7):211-219. PubMed ID: 38519377
[TBL] [Abstract][Full Text] [Related]
6. Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
Chen YB
Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
[TBL] [Abstract][Full Text] [Related]
7. ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
Doğan K; Onder E
Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
[TBL] [Abstract][Full Text] [Related]
8. Reclassifying Papillary, Oncocytic and Chromophobe Renal Tumours Based on the 5 < sup > th < /sup > Who Classification 2022.
Shaikh N; Mathew M
Turk Patoloji Derg; 2024; 40(2):122-127. PubMed ID: 38265103
[TBL] [Abstract][Full Text] [Related]
9. ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review.
Yang J; Dong L; Du H; Li XB; Liang YX; Liu GR
Diagn Pathol; 2019 Oct; 14(1):112. PubMed ID: 31627758
[TBL] [Abstract][Full Text] [Related]
10. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
Przybycin CG
Adv Anat Pathol; 2024 May; 31(3):147-156. PubMed ID: 38329413
[TBL] [Abstract][Full Text] [Related]
11. What's new in genitourinary pathology 2023: WHO 5th edition updates for urinary tract, prostate, testis, and penis.
Choy B; Tretiakova M; Zynger DL
J Pathol Transl Med; 2024 Jan; 58(1):45-48. PubMed ID: 38145904
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Genitourinary Tumors Updates From the 5th Edition of the World Health Organization Blue Book Series.
Riddle N; Parkash V; Guo CC; Shen SS; Perincheri S; Ramirez AS; Auerbach A; Belchis D; Humphrey P
Arch Pathol Lab Med; 2023 Nov; ():. PubMed ID: 38031818
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilic Solid and Cystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Study of 18 Cases and Review of the Literature.
Guo Q; Yao X; Yang B; Qi L; Wang F; Guo Y; Liu Y; Cao Z; Wang Y; Wang J; Li L; Huang Q; Liu C; Qu T; Zhao W; Ren D; Yang M; Yan C; Meng B; Wang C; Cao W
Arch Pathol Lab Med; 2024 Jan; ():. PubMed ID: 38282571
[TBL] [Abstract][Full Text] [Related]
14. [Pay attention to the updates of 5th edition WHO classification of haematolymphoid tumours].
Wang Z; Li XQ
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):3-5. PubMed ID: 38178738
[TBL] [Abstract][Full Text] [Related]
15. The 5th Edition of the World Health Organization (WHO) Classification of Hematolymphoid Tumors: What's New in Pediatrics?
Mohapatra D; Seth R; Mallick S
Indian Pediatr; 2024 Jan; 61(1):69-74. PubMed ID: 38183257
[TBL] [Abstract][Full Text] [Related]
16. Revising the WHO classification: female genital tract tumours.
Cree IA; White VA; Indave BI; Lokuhetty D
Histopathology; 2020 Jan; 76(1):151-156. PubMed ID: 31846528
[TBL] [Abstract][Full Text] [Related]
17. A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era.
Pfister SM; Reyes-Múgica M; Chan JKC; Hasle H; Lazar AJ; Rossi S; Ferrari A; Jarzembowski JA; Pritchard-Jones K; Hill DA; Jacques TS; Wesseling P; López Terrada DH; von Deimling A; Kratz CP; Cree IA; Alaggio R
Cancer Discov; 2022 Feb; 12(2):331-355. PubMed ID: 34921008
[TBL] [Abstract][Full Text] [Related]
18. Cytologic features of mesenchymal, melanocytic and haematolymphoid tumours of the central nervous system and metastases.
Bárcena C; Jiménez-Heffernan JA
Cytopathology; 2023 Oct; ():. PubMed ID: 37877651
[TBL] [Abstract][Full Text] [Related]
19. The World Health Organization Classification of Tumors and External Quality Assurance for Immunohistochemistry and Molecular Pathology.
Cree IA; Lokuhetty D; Tan PH
Arch Pathol Lab Med; 2022 Nov; 146(11):1303-1307. PubMed ID: 35671156
[TBL] [Abstract][Full Text] [Related]
20. Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung.
Del Aguila Mejía J; Armon S; Campbell F; Colling R; Chechlinska M; Kowalewska M; Pollán M; Holdenrieder S; Tan PH; Cree I; Indave Ruiz BI
BMJ Open; 2022 Oct; 12(10):e061240. PubMed ID: 36220326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
